COL1A1 and hepatocellular carcinoma: COL1A1 overexpression has been reported across several malignancies, including breast, gastric, and hepatocellular carcinoma (Geng et al., 2021; Li et al., 2022b), and is associated with poor prognosis, metastasis, and drug resistance (Li et al., 2022b).